Skip to content

Clinical application value of ultrasonic evaluation index of endometrial receptivity

The application value of ultrasonographic evaluation index of endometrial receptivity in pregnancy outcome in assisted reproductive technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060114
Enrollment
Unknown
Registered
2022-05-19
Start date
2022-05-07
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

First Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Female patients who plan to undergo assisted reproductive technology without contraceptive infertility for more than 2 years; 2. Obtain informed consent of patients and their families, pass the hospital ethics application (in the process of application), and pass the clinical trial registration (after the ethical application is approved); 3. Aged 22-45 years.

Exclusion criteria

Exclusion criteria: 1. Uterine malformation; 2. History of acute genital tract inflammation, endometrial adhesion or adhesion decomposition; 3. Endometrial polyps, endometriosis, uterine and adnexal masses, etc.; 4. Hypertension; 5. Autoimmune diseases; 6. Polycystic ovary syndrome, hyperprolactin syndrome, diabetes, thyroid dysfunction and other endocrine diseases.

Design outcomes

Primary

MeasureTime frame
endometrial microflow;

Secondary

MeasureTime frame
endometrial thickness ;

Countries

China

Contacts

Public ContactWang Longxia

The First Medical Center of Chinese PLA General Hospital

13693685342@163.com+86 13693685342

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026